Transplant in ALL: who, when, and how?

Keyphrases

• Acute Lymphoblastic Leukemia 100%
• Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) 100%
• Minimal Residual Disease 50%
• Advanced Disease 25%
• Patient Selection 25%
• Molecular Characterization 25%
• High-risk Acute Leukemia 25%
• Treatment Strategy 25%
• Low-risk Patients 25%
• Conditioning Regimen 25%
• Reduced-intensity Conditioning 25%
• Risk Assessment 25%
• Adult Patients 25%
• First Remission 25%
• Targeted Treatment 25%
• Novel Therapies 25%
• Treatment Protocol 25%
• Relapse Predictors 25%
• Modern Therapy 25%
• Optimal Sequence 25%
• Haploidentical Transplantation 25%
• Donor Selection 25%
• Deep Remission 25%

Medicine and Dentistry

• Acute Lymphoblastic Leukemia 100%
• Transplantation 100%
• Allogeneic Hematopoietic Stem Cell Transplantation 80%
• Minimal Residual Disease 40%
• Diseases 20%
• Targeted Therapy 20%
• Immunotherapy 20%
• Patient Selection 20%
• Conditioning 20%
• Reduced Intensity Conditioning 20%
• Donor Selection 20%
• Haploidentical Transplantation 20%

Immunology and Microbiology

• Allogeneic Hematopoietic Stem Cell Transplantation 100%
• Conditioning 50%
• Immunotherapy 25%
• Donor Selection 25%